TIDMSHP
Director/PDMR Shareholding
December 14, 2018 -- Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company")
Notification of transactions by person discharging managerial
responsibilities
Details of the person discharging managerial
responsibilities ("PDMR") / person closely
1. associated with them ("PCA")
--- -----------------------------------------------------------------------
a) Name Bill Mordan
--- -------------------------- -------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------------------
General Counsel and Company Secretary
a) Position / status - PDMR
--- -------------------------- -------------------------------------------
Initial notification
b) / amendment Initial notification
--- -------------------------- -------------------------------------------
Details of the issuer, emission allowance
participant, auction platform, auctioneer
3. or auction monitor
--- -----------------------------------------------------------------------
a) Name Shire plc
--- -------------------------- -------------------------------------------
b) LEI 54930005LQRLI2UXRQ59
--- -------------------------- -------------------------------------------
Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
4. have been conducted
--- -----------------------------------------------------------------------
Description
of the financial
instrument, Shire plc American Depositary
type of instrument Shares ("ADSs")
---
Identification
a) code ISIN: US82481R1068
--- -------------------------- -------------------------------------------
Receipt of ADSs following the
vesting of Performance Stock Units
("PSUs") awarded under the Shire
Long Term Incentive Plan 2015
("LTIP") on February 26, 2016.
In accordance with:
(i) the Co-Operation Agreement
between the Company and Takeda
Pharmaceutical Company Limited
dated May 8, 2018, and the rules
of the LTIP:
a. 100% of the PSUs vested pursuant
to applicable performance conditions;
b. vesting of the PSUs was accelerated
relative to the normal vesting
date; and
(ii) the rules of the LTIP, upon
vesting the number of ADSs to
be delivered was increased by
an amount equivalent to the value
of dividends paid by the Company
in respect of the PSUs from the
award date to the date of vesting.
(Details of related disposal of
Nature of the ADSs are referenced in section
b) transaction 5. below.)
--- -------------------------- -------------------------------------------
Price(s) Volume(s)
--- -------------------------- ---------------------- -------------------
Price(s) and
c) volume(s) $ 0 8,853
--- -------------------------- ------------------ -------------------
Aggregated information
- Aggregated
d) volume - Price N/A (single transaction)
--- -------------------------- -------------------------------------------
Date of the
e) transaction December 11, 2018
--- -------------------------- -------------------------------------------
Place of the
f) transaction N/A
--- -------------------------- -------------------------------------------
Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
5. have been conducted
--- -----------------------------------------------------------------------
Description
of the financial
instrument, Shire plc American Depositary
type of instrument Shares ("ADSs")
---
Identification
a) code ISIN: US82481R1068
--- -------------------------- -------------------------------------------
Automated disposal of ADSs in
relation to the vesting of PSUs
referenced in section 4. above.
The proceeds of this disposal
were used to satisfy personal
Nature of the tax liabilities arising from the
b) transaction vesting of the PSUs.
--- -------------------------- -------------------------------------------
Price(s) Volume(s)
--- -------------------------- ---------------------- -------------------
Price(s) and
c) volume(s) $ 169.6625 3,983
--- -------------------------- ------------------ -------------------
d) Aggregated information N/A (single transaction)
- Aggregated
volume - Price
--- -------------------------- -------------------------------------------
e) Date of the December 11, 2018
transaction
--- -------------------------- -------------------------------------------
f) Place of the NASDAQ
transaction
--- -------------------------- -------------------------------------------
Details of the person discharging managerial
responsibilities ("PDMR") / person closely
1. associated with them ("PCA")
---- -----------------------------------------------------------------------
a) Name Joanne Cordeiro
---- -------------------------- -------------------------------------------
2. Reason for the notification
---- -----------------------------------------------------------------------
Chief Human Resources Officer
a) Position / status -- PDMR
---- -------------------------- -------------------------------------------
Initial notification
b) / amendment Initial notification
---- -------------------------- -------------------------------------------
Details of the issuer, emission allowance
participant, auction platform, auctioneer
3. or auction monitor
---- -----------------------------------------------------------------------
a) Name Shire plc
---- -------------------------- -------------------------------------------
b) LEI 54930005LQRLI2UXRQ59
---- -------------------------- -------------------------------------------
Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
4. have been conducted
---- -----------------------------------------------------------------------
Description
of the financial
instrument, Shire plc American Depositary
type of instrument Shares ("ADSs")
----
Identification
a) code ISIN: US82481R1068
---- -------------------------- -------------------------------------------
Receipt of ADSs following the
vesting of Performance Stock Units
("PSUs") awarded under the Shire
Long Term Incentive Plan 2015
("LTIP") on May 1, 2018. In accordance
with:
(i) the Co-Operation Agreement
between the Company and Takeda
Pharmaceutical Company Limited
dated May 8, 2018, and the rules
of the LTIP:
a. 100% of the PSUs vested pursuant
to applicable performance conditions;
b. vesting of the PSUs was accelerated
relative to the normal vesting
date; and
(ii) the rules of the LTIP, upon
vesting the number of ADSs to
be delivered was increased by
an amount equivalent to the value
of dividends paid by the Company
in respect of the PSUs from the
award date to the date of vesting.
(Details of related disposal of
Nature of the ADSs are referenced in section
b) transaction 5. below.)
---- -------------------------- -------------------------------------------
Price(s) Volume(s)
---- -------------------------- ---------------------- -------------------
Price(s) and
c) volume(s) $ 0 12,050
---- -------------------------- ------------------ -------------------
Aggregated information
- Aggregated
d) volume - Price N/A (single transaction)
---- -------------------------- -------------------------------------------
Date of the
e) transaction December 11, 2018
---- -------------------------- -------------------------------------------
Place of the
f) transaction N/A
---- -------------------------- -------------------------------------------
Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
5. have been conducted
---- -----------------------------------------------------------------------
Description
of the financial
instrument, Shire plc American Depositary
type of instrument Shares ("ADSs")
----
Identification
a) code ISIN: US82481R1068
---- -------------------------- -------------------------------------------
Automated disposal of ADSs in
relation to the vesting of PSUs
referenced in section 4. above.
The proceeds of this disposal
were used to satisfy personal
Nature of the tax liabilities arising from the
b) transaction vesting of the PSUs.
---- -------------------------- -------------------------------------------
Price(s) Volume(s)
---- -------------------------- ---------------------- -------------------
Price(s) and
c) volume(s) $ 169.6625 5,420
---- -------------------------- ------------------ -------------------
Aggregated information
- Aggregated
d) volume - Price N/A (single transaction)
---- -------------------------- -------------------------------------------
Date of the
e) transaction December 11, 2018
---- -------------------------- -------------------------------------------
Place of the
f) transaction NASDAQ
---- -------------------------- -------------------------------------------
Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
6. have been conducted
---- -----------------------------------------------------------------------
Description
of the financial
instrument, Shire plc American Depositary
type of instrument Shares ("ADSs")
----
Identification
a) code ISIN: US82481R1068
---- -------------------------- -------------------------------------------
Receipt of ADSs following the
vesting of Performance Stock Units
("PSUs") awarded under the Shire
Long Term Incentive Plan 2015
("LTIP") on February 26, 2016.
In accordance with:
(i) the Co-Operation Agreement
between the Company and Takeda
Pharmaceutical Company Limited
dated May 8, 2018, and the rules
of the LTIP:
a. 100% of the PSUs vested pursuant
to applicable performance conditions;
b. vesting of the PSUs was accelerated
relative to the normal vesting
date; and (ii) the rules of the
LTIP, upon vesting the number
of ADSs to be delivered was increased
by an amount equivalent to the
value of dividends paid by the
Company in respect of the PSUs
from the award date to the date
of vesting.
(Details of related disposal of
Nature of the ADSs are referenced in section
b) transaction 7. below.)
---- -------------------------- -------------------------------------------
Price(s) Volume(s)
---- -------------------------- ---------------------- -------------------
Price(s) and
c) volume(s) $ 0 494
---- -------------------------- ------------------ -------------------
Aggregated information
- Aggregated
d) volume - Price N/A (single transaction)
---- -------------------------- -------------------------------------------
Date of the
e) transaction December 11, 2018
---- -------------------------- -------------------------------------------
Place of the
f) transaction N/A
---- -------------------------- -------------------------------------------
Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
7. have been conducted
---- -----------------------------------------------------------------------
Description
of the financial
instrument, Shire plc American Depositary
type of instrument Shares ("ADSs")
----
Identification
a) code ISIN: US82481R1068
---- -------------------------- -------------------------------------------
Automated disposal of ADSs in
relation to the vesting of PSUs
referenced in section 6. above.
The proceeds of this disposal
were used to satisfy personal
Nature of the tax liabilities arising from the
b) transaction vesting of the PSUs.
---- -------------------------- -------------------------------------------
Price(s) Volume(s)
---- -------------------------- ---------------------- -------------------
Price(s) and
c) volume(s) $ 169.6625 224
---- -------------------------- ------------------ -------------------
Aggregated information
- Aggregated
d) volume - Price N/A (single transaction)
---- -------------------------- -------------------------------------------
Date of the
e) transaction December 11, 2018
---- -------------------------- -------------------------------------------
Place of the
f) transaction NASDAQ
---- -------------------------- -------------------------------------------
Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
8. have been conducted
---- -----------------------------------------------------------------------
Description
of the financial
instrument, Shire plc American Depositary
type of instrument Shares ("ADSs")
----
Identification
a) code ISIN: US82481R1068
---- -------------------------- -------------------------------------------
Receipt of ADSs following the
vesting of Restricted Stock Units
("RSUs") awarded under the Shire
Long Term Incentive Plan 2015
("LTIP") on August 24, 2017. In
accordance with:
(i) the Co-Operation Agreement
between the Company and Takeda
Pharmaceutical Company Limited
dated May 8, 2018, and the rules
of the LTIP, vesting of the RSUs
was accelerated relative to the
normal vesting date; and (ii)
the rules of the LTIP, upon vesting
the number of ADSs to be delivered
was increased by an amount equivalent
to the value of dividends paid
by the Company in respect of the
RSUs from the award date to the
date of vesting.
(Details of related disposal of
Nature of the ADSs are referenced in section
b) transaction 9. below.)
---- -------------------------- -------------------------------------------
Price(s) Volume(s)
---- -------------------------- ---------------------- -------------------
Price(s) and
c) volume(s) $ 0 1,410
---- -------------------------- ------------------ -------------------
Aggregated information
- Aggregated
d) volume - Price N/A (single transaction)
---- -------------------------- -------------------------------------------
Date of the
e) transaction December 11, 2018
---- -------------------------- -------------------------------------------
Place of the
f) transaction N/A
---- -------------------------- -------------------------------------------
Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
9. have been conducted
---- -----------------------------------------------------------------------
Description
of the financial
instrument, Shire plc American Depositary
type of instrument Shares ("ADSs")
----
Identification
a) code ISIN: US82481R1068
---- -------------------------- -------------------------------------------
Automated disposal of ADSs in
relation to the vesting of RSUs
referenced in section 8. above.
The proceeds of this disposal
were used to satisfy personal
Nature of the tax liabilities arising from the
b) transaction vesting of the RSUs.
---- -------------------------- -------------------------------------------
Price(s) Volume(s)
---- -------------------------- ---------------------- -------------------
Price(s) and
c) volume(s) $ 169.6625 633
---- -------------------------- ------------------ -------------------
Aggregated information
- Aggregated
d) volume - Price N/A (single transaction)
---- -------------------------- -------------------------------------------
Date of the
e) transaction December 11, 2018
---- -------------------------- -------------------------------------------
Place of the
f) transaction NASDAQ
---- -------------------------- -------------------------------------------
Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
10. have been conducted
---- -----------------------------------------------------------------------
Description
of the financial
instrument, Shire plc American Depositary
type of instrument Shares ("ADSs")
----
Identification
a) code ISIN: US82481R1068
---- -------------------------- -------------------------------------------
Receipt of ADSs following the
vesting of Restricted Stock Units
("RSUs") awarded under the Shire
Long Term Incentive Plan 2015
("LTIP") on February 28, 2017.
In accordance with:
(i) the Co-Operation Agreement
between the Company and Takeda
Pharmaceutical Company Limited
dated May 8, 2018, and the rules
of the LTIP, vesting of the RSUs
was accelerated relative to the
normal vesting date; and (ii)
the rules of the LTIP, upon vesting
the number of ADSs to be delivered
was increased by an amount equivalent
to the value of dividends paid
by the Company in respect of the
RSUs from the award date to the
date of vesting.
(Details of related disposal of
Nature of the ADSs are referenced in section
b) transaction 11. below.)
---- -------------------------- -------------------------------------------
Price(s) Volume(s)
---- -------------------------- ---------------------- -------------------
Price(s) and
c) volume(s) $ 0 104
---- -------------------------- ------------------ -------------------
Aggregated information
- Aggregated
d) volume - Price N/A (single transaction)
---- -------------------------- -------------------------------------------
Date of the
e) transaction December 11, 2018
---- -------------------------- -------------------------------------------
Place of the
f) transaction N/A
---- -------------------------- -------------------------------------------
Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
11. have been conducted
---- -----------------------------------------------------------------------
Description
of the financial
instrument, Shire plc American Depositary
type of instrument Shares ("ADSs")
----
Identification
a) code ISIN: US82481R1068
---- -------------------------- -------------------------------------------
Automated disposal of ADSs in
relation to the vesting of RSUs
referenced in section 10. above.
The proceeds of this disposal
were used to satisfy personal
Nature of the tax liabilities arising from the
b) transaction vesting of the RSUs.
---- -------------------------- -------------------------------------------
Price(s) Volume(s)
---- -------------------------- ---------------------- -------------------
Price(s) and
c) volume(s) $ 169.6625 47
---- -------------------------- ------------------ -------------------
Aggregated information
- Aggregated
d) volume - Price N/A (single transaction)
---- -------------------------- -------------------------------------------
Date of the
e) transaction December 11, 2018
---- -------------------------- -------------------------------------------
Place of the
f) transaction NASDAQ
---- -------------------------- -------------------------------------------
Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
12. have been conducted
---- -----------------------------------------------------------------------
Description
of the financial
instrument, Shire plc American Depositary
type of instrument Shares ("ADSs")
----
Identification
a) code ISIN: US82481R1068
---- -------------------------- -------------------------------------------
Receipt of ADSs following the
vesting of Restricted Stock Units
("RSUs") awarded under the Shire
Long Term Incentive Plan 2015
("LTIP") on February 26, 2016.
In accordance with:
(i) the Co-Operation Agreement
between the Company and Takeda
Pharmaceutical Company Limited
dated May 8, 2018, and the rules
of the LTIP, vesting of the RSUs
was accelerated relative to the
normal vesting date; and (ii)
the rules of the LTIP, upon vesting
the number of ADSs to be delivered
was increased by an amount equivalent
to the value of dividends paid
by the Company in respect of the
RSUs from the award date to the
date of vesting.
(Details of related disposal of
Nature of the ADSs are referenced in section
b) transaction 13. below.)
---- -------------------------- -------------------------------------------
Price(s) Volume(s)
---- -------------------------- ---------------------- -------------------
Price(s) and
c) volume(s) $ 0 173
---- -------------------------- ------------------ -------------------
Aggregated information
- Aggregated
d) volume - Price N/A (single transaction)
---- -------------------------- -------------------------------------------
Date of the
e) transaction December 11, 2018
---- -------------------------- -------------------------------------------
Place of the
f) transaction N/A
---- -------------------------- -------------------------------------------
Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
13. have been conducted
---- -----------------------------------------------------------------------
Description
of the financial
instrument, Shire plc American Depositary
type of instrument Shares ("ADSs")
----
Identification
a) code ISIN: US82481R1068
---- -------------------------- -------------------------------------------
Automated disposal of ADSs in
relation to the vesting of RSUs
referenced in section 12. above.
The proceeds of this disposal
were used to satisfy personal
Nature of the tax liabilities arising from the
b) transaction vesting of the RSUs.
---- -------------------------- -------------------------------------------
Price(s) Volume(s)
---- -------------------------- ---------------------- -------------------
Price(s) and
c) volume(s) $ 169.6625 79
---- -------------------------- ------------------ -------------------
d) Aggregated information N/A (single transaction)
- Aggregated
volume - Price
---- -------------------------- -------------------------------------------
e) Date of the December 11, 2018
transaction
---- -------------------------- -------------------------------------------
f) Place of the NASDAQ
transaction
---- -------------------------- -------------------------------------------
Details of the person discharging managerial
responsibilities ("PDMR") / person closely
1. associated with them ("PCA")
---- -----------------------------------------------------------------------
a) Name Perry Sternberg
---- -------------------------- -------------------------------------------
2. Reason for the notification
---- -----------------------------------------------------------------------
a) Position / status Head of US Commercial - PDMR
---- -------------------------- -------------------------------------------
Initial notification
b) / amendment Initial notification
---- -------------------------- -------------------------------------------
Details of the issuer, emission allowance
participant, auction platform, auctioneer
3. or auction monitor
---- -----------------------------------------------------------------------
a) Name Shire plc
---- -------------------------- -------------------------------------------
b) LEI 54930005LQRLI2UXRQ59
---- -------------------------- -------------------------------------------
Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
4. have been conducted
---- -----------------------------------------------------------------------
Description
of the financial
instrument, Shire plc American Depositary
type of instrument Shares ("ADSs")
----
Identification
a) code ISIN: US82481R1068
---- -------------------------- -------------------------------------------
Receipt of ADSs following the
vesting of Restricted Stock Units
("RSUs") awarded under the Shire
Long Term Incentive Plan 2015
("LTIP") on August 5, 2016. In
accordance with:
(i) the Co-Operation Agreement
between the Company and Takeda
Pharmaceutical Company Limited
dated May 8, 2018, and the rules
of the LTIP, vesting of the RSUs
was accelerated relative to the
normal vesting date; and (ii)
the rules of the LTIP, upon vesting
the number of ADSs to be delivered
was increased by an amount equivalent
to the value of dividends paid
by the Company in respect of the
RSUs from the award date to the
date of vesting.
(Details of related disposal of
Nature of the ADSs are referenced in section
b) transaction 5. below.)
---- -------------------------- -------------------------------------------
Price(s) Volume(s)
---- -------------------------- ---------------------- -------------------
Price(s) and
c) volume(s) $ 0 1,011
---- -------------------------- ------------------ -------------------
Aggregated information
- Aggregated
d) volume - Price N/A (single transaction)
---- -------------------------- -------------------------------------------
Date of the
e) transaction December 11, 2018
---- -------------------------- -------------------------------------------
Place of the
f) transaction N/A
---- -------------------------- -------------------------------------------
Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
5. have been conducted
---- -----------------------------------------------------------------------
Description
of the financial
instrument, Shire plc American Depositary
type of instrument Shares ("ADSs")
----
Identification
a) code ISIN: US82481R1068
---- -------------------------- -------------------------------------------
Automated disposal of ADSs in
relation to the vesting of RSUs
referenced in section 4. above.
The proceeds of this disposal
were used to satisfy personal
Nature of the tax liabilities arising from the
b) transaction vesting of the RSUs.
---- -------------------------- -------------------------------------------
Price(s) Volume(s)
---- -------------------------- ---------------------- -------------------
Price(s) and
c) volume(s) $ 169.6625 388
---- -------------------------- ------------------ -------------------
Aggregated information
- Aggregated
d) volume - Price N/A (single transaction)
---- -------------------------- -------------------------------------------
Date of the
e) transaction December 11, 2018
---- -------------------------- -------------------------------------------
Place of the
f) transaction NASDAQ
---- -------------------------- -------------------------------------------
Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
6. have been conducted
---- -----------------------------------------------------------------------
Description
of the financial
instrument, Shire plc American Depositary
type of instrument Shares ("ADSs")
----
Identification
a) code ISIN: US82481R1068
---- -------------------------- -------------------------------------------
Receipt of ADSs following the
vesting of Restricted Stock Units
("RSUs") awarded under the Shire
Long Term Incentive Plan 2015
("LTIP") on February 26, 2016.
In accordance with:
(i) the Co-Operation Agreement
between the Company and Takeda
Pharmaceutical Company Limited
dated May 8, 2018, and the rules
of the LTIP, vesting of the RSUs
was accelerated relative to the
normal vesting date; and (ii)
the rules of the LTIP, upon vesting
the number of ADSs to be delivered
was increased by an amount equivalent
to the value of dividends paid
by the Company in respect of the
RSUs from the award date to the
date of vesting.
(Details of related disposal of
Nature of the ADSs are referenced in section
b) transaction 7. below.)
---- -------------------------- -------------------------------------------
Price(s) Volume(s)
---- -------------------------- ---------------------- -------------------
Price(s) and
c) volume(s) $ 0 441
---- -------------------------- ------------------ -------------------
Aggregated information
- Aggregated
d) volume - Price N/A (single transaction)
---- -------------------------- -------------------------------------------
Date of the
e) transaction December 11, 2018
---- -------------------------- -------------------------------------------
Place of the
f) transaction N/A
---- -------------------------- -------------------------------------------
Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
7. have been conducted
---- -----------------------------------------------------------------------
Description
of the financial
instrument, Shire plc American Depositary
type of instrument Shares ("ADSs")
----
Identification
a) code ISIN: US82481R1068
---- -------------------------- -------------------------------------------
Automated disposal of ADSs in
relation to the vesting of RSUs
referenced in section 6. above.
The proceeds of this disposal
were used to satisfy personal
Nature of the tax liabilities arising from the
b) transaction vesting of the RSUs.
---- -------------------------- -------------------------------------------
Price(s) Volume(s)
---- -------------------------- ---------------------- -------------------
Price(s) and
c) volume(s) $ 169.6625 133
---- -------------------------- ------------------ -------------------
Aggregated information
- Aggregated
d) volume - Price N/A (single transaction)
---- -------------------------- -------------------------------------------
Date of the
e) transaction December 11, 2018
---- -------------------------- -------------------------------------------
Place of the
f) transaction NASDAQ
---- -------------------------- -------------------------------------------
Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
8. have been conducted
---- -----------------------------------------------------------------------
Description
of the financial
instrument, Shire plc American Depositary
type of instrument Shares ("ADSs")
----
Identification
a) code ISIN: US82481R1068
---- -------------------------- -------------------------------------------
Receipt of ADSs following the
vesting of Performance Stock Units
("PSUs") awarded under the Shire
Long Term Incentive Plan 2015
("LTIP") on February 26, 2016.
In accordance with:
(i) the Co-Operation Agreement
between the Company and Takeda
Pharmaceutical Company Limited
dated May 8, 2018, and the rules
of the LTIP:
a. 100% of the PSUs vested pursuant
to applicable performance conditions;
b. vesting of the PSUs was accelerated
relative to the normal vesting
date; and
(ii) the rules of the LTIP, upon
vesting the number of ADSs to
be delivered was increased by
an amount equivalent to the value
of dividends paid by the Company
in respect of the PSUs from the
award date to the date of vesting.
(Details of related disposals
Nature of the of ADSs are referenced in sections
b) transaction 10. and 11. below.)
---- -------------------------- -------------------------------------------
Price(s) Volume(s)
---- -------------------------- ---------------------- -------------------
Price(s) and
c) volume(s) $ 0 1,260
---- -------------------------- ------------------ -------------------
Aggregated information
- Aggregated
d) volume - Price N/A (single transaction)
---- -------------------------- -------------------------------------------
Date of the
e) transaction December 11, 2018
---- -------------------------- -------------------------------------------
Place of the
f) transaction N/A
---- -------------------------- -------------------------------------------
Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
9. have been conducted
---- -----------------------------------------------------------------------
Description
of the financial
instrument, Shire plc American Depositary
type of instrument Shares ("ADSs")
----
Identification
a) code ISIN: US82481R1068
---- -------------------------- -------------------------------------------
Receipt of ADSs following the
vesting of Performance Stock Units
("PSUs") awarded under the Shire
Long Term Incentive Plan 2015
("LTIP") on February 28, 2017.
In accordance with:
(i) the Co-Operation Agreement
between the Company and Takeda
Pharmaceutical Company Limited
dated May 8, 2018, and the rules
of the LTIP:
a. 87% of the PSUs vested pursuant
to applicable performance conditions;
b. vesting of the PSUs was accelerated
relative to the normal vesting
date; and
(ii) the rules of the LTIP, upon
vesting the number of ADSs to
be delivered was increased by
an amount equivalent to the value
of dividends paid by the Company
in respect of the PSUs from the
award date to the date of vesting.
(Details of related disposals
Nature of the of ADSs are referenced in sections
b) transaction 10. and 11. below.)
---- -------------------------- -------------------------------------------
Price(s) Volume(s)
---- -------------------------- ---------------------- -------------------
Price(s) and
c) volume(s) $ 0 7,790
---- -------------------------- ------------------ -------------------
Aggregated information
- Aggregated
d) volume - Price N/A (single transaction)
---- -------------------------- -------------------------------------------
Date of the
e) transaction December 11, 2018
---- -------------------------- -------------------------------------------
Place of the
f) transaction N/A
---- -------------------------- -------------------------------------------
Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
10. have been conducted
---- -----------------------------------------------------------------------
Description
of the financial
instrument, Shire plc American Depositary
type of instrument Shares ("ADSs")
----
Identification
a) code ISIN: US82481R1068
---- -------------------------- -------------------------------------------
Automated disposal of ADSs in
relation to the vesting of PSUs
referenced in sections 8 and 9.
above. The proceeds of this disposal
were used to satisfy personal
Nature of the tax liabilities arising from the
b) transaction vesting of the PSUs.
---- -------------------------- -------------------------------------------
Price(s) Volume(s)
---- -------------------------- ---------------------- -------------------
Price(s) and
c) volume(s) $ 169.6625 3,940
---- -------------------------- ------------------ -------------------
Aggregated information
- Aggregated
d) volume - Price N/A (single transaction)
---- -------------------------- -------------------------------------------
Date of the
e) transaction December 11, 2018
---- -------------------------- -------------------------------------------
Place of the
f) transaction NASDAQ
---- -------------------------- -------------------------------------------
Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
11. have been conducted
---- -----------------------------------------------------------------------
Description
of the financial
instrument, Shire plc American Depositary
type of instrument Shares ("ADSs")
----
Identification
a) code ISIN: US82481R1068
---- -------------------------- -------------------------------------------
Automated disposal of ADSs in
relation to the vesting of PSUs
referenced in sections 8. and
9. above. The proceeds of this
disposal were used to satisfy
Nature of the personal tax liabilities arising
b) transaction from the vesting of the PSUs.
---- -------------------------- -------------------------------------------
Price(s) Volume(s)
---- -------------------------- ---------------------- -------------------
Price(s) and
c) volume(s) $ 175.1500 91
---- -------------------------- ------------------ -------------------
d) Aggregated information N/A (single transaction)
- Aggregated
volume - Price
---- -------------------------- -------------------------------------------
e) Date of the December 13, 2018
transaction
---- -------------------------- -------------------------------------------
f) Place of the NASDAQ
transaction
---- -------------------------- -------------------------------------------
Details of the person discharging managerial
responsibilities ("PDMR") / person closely
1. associated with them ("PCA")
--- -----------------------------------------------------------------------
a) Name Matt Walker
--- -------------------------- -------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------------------
Head of Technical Operations --
a) Position / status PDMR
--- -------------------------- -------------------------------------------
Initial notification
b) / amendment Initial notification
--- -------------------------- -------------------------------------------
Details of the issuer, emission allowance
participant, auction platform, auctioneer
3. or auction monitor
--- -----------------------------------------------------------------------
a) Name Shire plc
--- -------------------------- -------------------------------------------
b) LEI 54930005LQRLI2UXRQ59
--- -------------------------- -------------------------------------------
Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
4. have been conducted
--- -----------------------------------------------------------------------
Description
of the financial
instrument, Shire plc American Depositary
type of instrument Shares ("ADSs")
---
Identification
a) code ISIN: US82481R1068
--- -------------------------- -------------------------------------------
Receipt of ADSs following the
vesting of Performance Stock Units
("PSUs") awarded under the Shire
Long Term Incentive Plan 2015
("LTIP") on May 1, 2018. In accordance
with:
(i) the Co-Operation Agreement
between the Company and Takeda
Pharmaceutical Company Limited
dated May 8, 2018, and the rules
of the LTIP:
a. 100% of the PSUs vested pursuant
to applicable performance conditions;
b. vesting of the PSUs was accelerated
relative to the normal vesting
date; and
(ii) the rules of the LTIP, upon
vesting the number of ADSs to
be delivered was increased by
an amount equivalent to the value
of dividends paid by the Company
in respect of the PSUs from the
award date to the date of vesting.
(Details of related disposal of
Nature of the ADSs are referenced in section
b) transaction 5. below.)
--- -------------------------- -------------------------------------------
Price(s) Volume(s)
--- -------------------------- ---------------------- -------------------
Price(s) and
c) volume(s) $ 0 12,665
--- -------------------------- ------------------ -------------------
Aggregated information
- Aggregated
d) volume - Price N/A (single transaction)
--- -------------------------- -------------------------------------------
Date of the
e) transaction December 11, 2018
--- -------------------------- -------------------------------------------
Place of the
f) transaction N/A
--- -------------------------- -------------------------------------------
Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
5. have been conducted
--- -----------------------------------------------------------------------
Description
of the financial
instrument, Shire plc American Depositary
type of instrument Shares ("ADSs")
---
Identification
a) code ISIN: US82481R1068
--- -------------------------- -------------------------------------------
Automated disposal of ADSs in
relation to the vesting of PSUs
referenced in section 4. above.
The proceeds of this disposal
were used to satisfy personal
Nature of the tax liabilities arising from the
b) transaction vesting of the PSUs.
--- -------------------------- -------------------------------------------
Price(s) Volume(s)
--- -------------------------- ---------------------- -------------------
Price(s) and
c) volume(s) $ 169.6625 5,652
--- -------------------------- ------------------ -------------------
Aggregated information
- Aggregated
d) volume - Price N/A (single transaction)
--- -------------------------- -------------------------------------------
Date of the
e) transaction December 11, 2018
--- -------------------------- -------------------------------------------
Place of the
f) transaction NASDAQ
--- -------------------------- -------------------------------------------
Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
6. have been conducted
--- -----------------------------------------------------------------------
Description
of the financial
instrument, Shire plc American Depositary
type of instrument Shares ("ADSs")
---
Identification
a) code ISIN: US82481R1068
--- -------------------------- -------------------------------------------
Receipt of ADSs following the
vesting of Performance Stock Units
("PSUs") awarded under the Shire
Long Term Incentive Plan 2015
("LTIP") on May 2, 2016. In accordance
with:
(i) the Co-Operation Agreement
between the Company and Takeda
Pharmaceutical Company Limited
dated May 8, 2018, and the rules
of the LTIP:
a. 100% of the PSUs vested pursuant
to applicable performance conditions;
b. vesting of the PSUs was accelerated
relative to the normal vesting
date; and
(ii) the rules of the LTIP, upon
vesting the number of ADSs to
be delivered was increased by
an amount equivalent to the value
of dividends paid by the Company
in respect of the PSUs from the
award date to the date of vesting.
(Details of related disposal of
Nature of the ADSs are referenced in section
b) transaction 7. below.)
--- -------------------------- -------------------------------------------
Price(s) Volume(s)
--- -------------------------- ---------------------- -------------------
Price(s) and
c) volume(s) $ 0 3,292
--- -------------------------- ------------------ -------------------
Aggregated information
- Aggregated
d) volume - Price N/A (single transaction)
--- -------------------------- -------------------------------------------
Date of the
e) transaction December 11, 2018
--- -------------------------- -------------------------------------------
Place of the
f) transaction N/A
--- -------------------------- -------------------------------------------
Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
7. have been conducted
--- -----------------------------------------------------------------------
Description
of the financial
instrument, Shire plc American Depositary
type of instrument Shares ("ADSs")
---
Identification
a) code ISIN: US82481R1068
--- -------------------------- -------------------------------------------
Automated disposal of ADSs in
relation to the vesting of PSUs
referenced in section 6. above.
The proceeds of this disposal
were used to satisfy personal
Nature of the tax liabilities arising from the
b) transaction vesting of the PSUs.
--- -------------------------- -------------------------------------------
Price(s) Volume(s)
--- -------------------------- ---------------------- -------------------
Price(s) and
c) volume(s) $ 169.6625 983
--- -------------------------- ------------------ -------------------
d) Aggregated information N/A (single transaction)
- Aggregated
volume - Price
--- -------------------------- -------------------------------------------
e) Date of the December 11, 2018
transaction
--- -------------------------- -------------------------------------------
f) Place of the NASDAQ
transaction
--- -------------------------- -------------------------------------------
Oliver Strawbridge
Senior Assistant Company Secretary
For further information please contact:
Investor Relations
Christoph Brackmann christoph.brackmann@shire.com +41 41 288 41 29
Sun Kim sun.kim@shire.com +1 617 588 8175
Scott Burrows scott.burrows@shire.com +41 41 288 4195
Media
Katie Joyce kjoyce@shire.com +1 781 482 2779
NOTES TO EDITORS
About Shire
Shire is the global biotechnology leader serving patients with rare
diseases and specialized conditions. We seek to push boundaries through
discovering and delivering new possibilities for patient communities who
often have few or no other champions. Relentlessly on the edge of what's
next, we are serial innovators with a diverse pipeline offering fresh
thinking and new hope. Serving patients and partnering with healthcare
communities in over 100 countries, we strive to be part of the entire
patient journey to enable earlier diagnosis, raise standards of care,
accelerate access to treatment, and support patients. Our diverse
portfolio of therapeutic areas includes Immunology, Hematology, Genetic
Diseases, Neuroscience, Internal Medicine, and Ophthalmics.
Championing patients is our call to action - it brings the opportunity -
and responsibility - to change people's lives.
www.shire.com
(END) Dow Jones Newswires
December 14, 2018 08:15 ET (13:15 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
Shire (NASDAQ:SHPGY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Shire (NASDAQ:SHPGY)
Historical Stock Chart
From Apr 2023 to Apr 2024
